PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model
cannabis investing PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund
cannabis investing PreveCeutical Announces the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program
cannabis investing PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
Cartier Cuts 11.0 g/t Au over 9.0 m including 30.2 g/t Au over 2.5 at Contact ; Continues to Expand High-Grade Gold North Contact Zone near Surface
Torchlight Innovations (Doing Business as RZOLV Technologies) Announces Preliminary Positive Results on Rare Earth and Critical Mineral Recoveries
